Hepatic localisation of rat cysteine dioxygenase

Journal of Hepatology

Volumn 29, Issue 4, 1998, Pages 595-602

  Parsons, Richard B ^a   Ramsden, David B ^a,b   Waring, Rosemary H ^a   Barber, Peter C ^a   Williams, Adrian C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Amino acid; Anti CDO antibodies; Cysteine; Cysteine dioxygenase; Cysteinesulphinic acid; Sulphate; Taurine

Indexed keywords

CYSTEINE DERIVATIVE; CYSTEINE DIOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 16744361971     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80155-4     Document Type: Article

References (47)

1. 1. Pean AR, Steventon GB, Waring RH, Foster H, Sturman S Williams AC. Pathways of cysteine metabolism in MND/ ALS. J Neuro Sci 1994; 124 (Suppl.): 59-61.
2. 2. Sörbo B, Ewetz L. The enzymic oxidation of cysteine to cysteinesulfinate in rat liver. Biochem Biophys Res Commun 1965; 3: 359-63.
3. 2- and sulphur-containing amino acids as sources for macromolecular sulphation. J Physiol 1991; 260: L450-6.
4. 4. Galle PR, Theilmann L, Raedsch R, Rudolph G, Kommerell B, Stiehl A. Taurine and glycine conjugation and sulfation of lithocholate in primary hepatocyte cultures. Biochim Biophys Acta 1989; 1003: 250-3.
5. 5. Hepner GW, Sturman JR, Hofmann AF, Thomas PJ. Metabolism of steroid and amino acid moieties of conjugated bile acids in man 3. Cholyltaurine (taurocholic acid). J Clin Invest 1973; 52: 433-40.
6. 6. Loriette C, Pasantes-Morales H, Portemer C, Chatagner F. Dietary casein levels and taurine supplementation. Effects on cysteine dioxygenase and cysteine sulfinate decarboxylase activities and taurine concentration in brain, liver and kidney of the rat. Nutr Metab 1979; 23: 467-75.
7. 7. Misra CH, Olney JW. Cysteine oxidase in the brain. Brain Res 1975; 97: 117-26.
8. 8. Misra CH. In vitro study of cysteine oxidase in rat brain. Neurochem Res 1983; 8: 1497-508.
9. 9. Di Giorgio RM, Tucci G, Macalone S. Cysteine oxidase in rat retina during development. Life Sci 1975; 16: 429-36.
10. 10. Macalone S, Di Giorgio RM. Subcellular distribution of cysteine oxidase activity in ox retina. Life Sci 1977; 20: 617-22.
11. 11. Misra CH, Mishra SK. Evidence of cysteine oxidase in rat muscle. Biochem Pharmacol 1977; 26: 1101-2
12. 12. Hosokawa Y, Matsumoto A, Oka J, Itakura H, Yamaguchi K. Isolation and characterization of a cDNA for rat liver cysteine dioxygenase. Biochem Biophys Res Commun 1990; 168: 471-8.
13. 13. McCann KP, Akbari MT, Williams AC, Ramsden DB. Human cysteine dioxygenase type I: primary structure derived from base sequencing of cDNA. Biochim Biophys Acta 1994; 1209: 107-10.
14. 14. Jeremiah S, McCann KP, Williams AC, Ramsden DB, Pilz AJ, Fox MF, et al. Chromosomal localisation of genes coding for human and mouse liver cytosolic cysteine dioxygenase. Ann Hum Genet 1996; 60: 29-33.
15. 15. Yamaguchi K, Hosokawa Y. The stabilizing protein, protein-A, of cysteine dioxygenase. Adv Exp Med Biol 1987; 217: 29-38.
16. 16. Sakakibari S, Yamaguchi K, Ueda I, Sakamoto Y. Two components of cysteine oxidase in rat liver. Biochem Biophys Res Commun 1973; 52: 1093-9.
17. 17. Foster H. Characterisation and purification of cysteine dioxygenase in rat and human liver. MSc Thesis. The University of Birmingham, UK; 1992.
18. 18. Da Silva A. Enzymes and neurodegenerative disease: the purification of rat and pig cysteine dioxygenase enzymes. MSc Thesis. The University of Birmingham, UK; 1995.
19. 19. Hosokawa Y, Yamaguchi K, Kohashi N, Kori Y, Fujii O, Ueda I. Immaturity of the enzyme activity and the response to inducers of rat liver cysteine dioxygenase during development. J Biochem 1980; 88: 389-94.
20. 20. Kohashi N, Yamaguchi K, Hosokawa Y, Kori Y, Fujii O, Ueda I. Dietary control of cysteine dioxygenase in rat liver. J Biochem 1978; 84: 159-68.
21. 21. Daniels KM, Stipanuk MH. Effect of dietary cysteine levels on cysteine metabolism in rats. J Nutr 1982; 112: 2130-41.
22. 22. Stipanuk MH, Rotter LA. Metabolism of cysteine, cysteinesulfinic acid and cysteine sulfonate in rats fed adequate and excess levels of sulfur-containing amino acids. J Nutr 1984; 114: 1426-37.
23. 23. Bagley PJ, Stipanuk MH. Rats fed a low protein diet supplemented with sulfur amino acids have increased cysteine dioxygenase activity and increased taurine production in hepatocytes. J Nutr 1995; 125: 933-40.
24. 24. Stipanuk MH. Effect of excess dietary methionine on the catabolism of cysteine in rats. J Nutr 1979; 109: 2126-39.
25. 25. Mikami H, Hosaki Y, Ubuka T. Metabolism of L-cysteine in rats fed low and high protein diets. Acta Med Okayama 1984; 38: 415-21.
26. 26. Yamaguchi K, Sakakibara S, Koga K, Ueda I. Induction and activation of cysteine oxidase in rat liver I. The effects of cysteine, hydrocortisone and nicotinamide injection on hepatic cysteine oxidase and tyrosine transaminase activities of intact and adrenalectomized rats. Biochim Biophys Acta 1971; 237: 502-12.
27. 27. Emery P, Bradley H, Gough A, Arthur V. Jubb R, Waring RH. Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment. Ann Rheum Dis 1992; 51: 318-20.
28. 28. Perry TL, Norman MG, Yong VW, Whiting S, Crichton JU, Hansen S, et al. Hallervordern-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the Globus pallidus. Ann Neurol 1985; 18: 482-9.
29. 29. Heafield MT, Fern S, Steventon GB, Waring RH, Williams AC. Plasma cysteine and sulfate levels in patients with Amyotrophic Lateral Sclerosis, Alzheimer's disease and Parkinson's disease. Ann Neurosci Lett 1990; 110: 216-20.
30. 30. Tanner CM. Abnormal liver enzyme-mediated metabolism in Parkinson's disease. Ann Neurol 1991; 41 (Suppl. 2): 89-91.
31. 31. Utti RJ, Calne DB. Pathogenesis of idiopathic Parkinsonism. Eur J Neurol 1993; 33 (Suppl 1): 6-23.
32. 32. Lange KW, Youdim MB, Riederer P. Neurotoxicity and neuroprotection in Parkinson's disease. J Neural Transm Suppl 1992; 38: 27-44.
33. 33. Waring RH, Steventon GB, Sturman SG, Heafield MT. S-methylation in Motor Neuron disease and Parkinson's disease. Lancet 1989; ii: 356-7.
34. 34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
35. 35. Hirshchberger LL, Delarosa J, Stipanuk MH. Determination of cysteinesulfinate, hypotaurine and taurine in physiological samples by reversed-phase high-performance liquid chromatography. J Chromatogr 1985; 343: 303-13.
36. 36. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-32.
37. 37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
38. 38. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci 1979; 76: 4350-4.
39. 39. Neurath H. Proteolytic enzymes, past and present. Fed Proc 1985; 44: 2907-13.
40. 40. Wang SX, Mure M, Medzihradsky KF, Burlingame AL, Brown DE, Dooley DM, et al. A cross-linked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 1996; 273: 1078-84.
41. 41. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992; 22: 1-21.
42. 42. Ioannides C, Parkes DV. The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab Rev 1990; 22: 1-85.
43. 43. Lampe J, Butschak G. The role of cytochrome P450 in the toxicity of xenobiotics. Pharmazie 1978; 33: 407-11.
44. 44. Lamartiniere CA, Lucier GW. Endocrine regulation of xenobiotic conjugation enzymes. Basic Life Sci 1983; 24: 295-312.
45. 45. van der Werve G. Isolation and characteristics of hepatocytes. Toxicology 1980; 18: 179-85.
46. 46. Gebhardt R, Gaunitz F, Mecke D. Heterogenous (positional) expression of hepatic glutamine synthetase: features, regulation and implications for carcinogenesis. Adv Enz Reg 1994; 34: 27-56.
47. 47. Pentilla KE. Role of cysteine and taurine in regulating glutathione synthesis by periportal and perivenous hepatocytes. Biochem J 1990; 269: 659-64.